KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Amortization (2018 - 2020)

Historic Amortization for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Q3 2020 value amounting to $461.8 million.

  • Aurinia Pharmaceuticals' Amortization rose 179389.28% to $461.8 million in Q3 2020 from the same period last year, while for Sep 2020 it was $461.8 million, marking a year-over-year increase of 60445.63%. This contributed to the annual value of $326.7 million for FY2019, which is 12396.56% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Amortization of $461.8 million as of Q3 2020, which was up 179389.28% from -$21.9 million recorded in Q2 2020.
  • In the past 5 years, Aurinia Pharmaceuticals' Amortization registered a high of $461.8 million during Q3 2020, and its lowest value of -$21.9 million during Q2 2020.
  • Over the past 3 years, Aurinia Pharmaceuticals' median Amortization value was $15.0 million (recorded in 2019), while the average stood at $93.2 million.
  • The largest annual percentage gain for Aurinia Pharmaceuticals' Amortization in the last 5 years was 200402.14% (2020), contrasted with its biggest fall of 11450.17% (2020).
  • Aurinia Pharmaceuticals' Amortization (Quarter) stood at $14.6 million in 2018, then skyrocketed by 97.53% to $28.9 million in 2019, then skyrocketed by 1498.19% to $461.8 million in 2020.
  • Its last three reported values are $461.8 million in Q3 2020, -$21.9 million for Q2 2020, and $315.0 million during Q1 2020.